about
Invasive urodynamic studies for the management of lower urinary tract symptoms (LUTS) in men with voiding dysfunctionClinical use of the β3 adrenoceptor agonist mirabegron in patients with overactive bladder syndromeTotal urgency and frequency score as a measure of urgency and frequency in overactive bladder and storage lower urinary tract symptomsInvestigating the flow dynamics in the obstructed and stented ureter by means of a biomimetic artificial modelUrodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods (UPSTREAM) for diagnosis and management of bladder outlet obstruction in men: study protocol for a randomised controlled trial.An exploration of the control of micturition using a novel in situ arterially perfused rat preparation.A retrospective study of treatment persistence and adherence to α-blocker plus antimuscarinic combination therapies, in men with LUTS/BPH in the Netherlands.Potential insights into lower urinary function derived from CNS imaging.Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence.Etiology and management of urinary retention in women.Maximum urethral closure pressure in women: normative data and evaluation as a diagnostic test.Phasic contractions in urinary bladder from juvenile versus adult pigs.The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults.Anoctamin-1 in the juvenile rat urinary bladder.The integrative physiology of the bladderAn open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer.A proposed guideline for the urological management of patients with spinal cord injury.The use of ultrasound-estimated bladder weight in diagnosing bladder outlet obstruction and detrusor overactivity in men with lower urinary tract symptoms.Mechanisms of action of intravesical botulinum treatment in refractory detrusor overactivity.A functional analysis of the influence of β3-adrenoceptors on the rat micturition cycleNeural control of the lower urinary and gastrointestinal tracts: supraspinal CNS mechanisms.Animal models and their use in understanding lower urinary tract dysfunction.EAU guidelines on urinary incontinence.Urinary diaries: evidence for the development and validation of diary content, format, and duration.Animal models in overactive bladder research.Nocturia as a manifestation of systemic disease.Bladder outlet physiology in the context of lower urinary tract dysfunction.Managing unsatisfactory outcome after mid-urethral tape insertion.Developing a new treatment device: how to get an idea to the marketplace.How should bladder sensation be measured? ICI-RS 2011.The adult urology perspective on management of stress urinary incontinence in pediatric urology: ICI-RS 2011.Nocturia Think Tank: focus on nocturnal polyuria: ICI-RS 2011.The artificial urinary sphincter after a quarter of a century: a critical systematic review of its use in male non-neurogenic incontinence.Future direction in pharmacotherapy for non-neurogenic male lower urinary tract symptoms.The association between nocturia and nocturnal polyuria in clinical and epidemiological studies: a systematic review and meta-analyses.Impact of the International Continence Society (ICS) report on the standardisation of terminology in nocturia on the quality of reports on nocturia and nocturnal polyuria: a systematic review.Does altered myogenic activity contribute to OAB symptoms from detrusor overactivity? ICI-RS 2013.Voiding dysfunction due to detrusor underactivity: an overview.Physiological and pathophysiological implications of micromotion activity in urinary bladder function.EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.
P50
Q24186369-474F1363-86A7-4C8E-842A-008A12EC5482Q26783536-438E3DFD-C863-4268-8A4D-5CB983198EECQ27001248-6B7831A1-2733-490C-BBC1-F9234F810386Q27324595-B60ACBB9-B970-4707-AC69-2DE460A1B9D8Q27335093-83CD3D0D-4589-45F0-A3CA-044D884EBFB3Q30500299-D10E6EF0-8FC3-4F62-8BD8-CFE7B1FE2AC3Q33716568-B99C1178-297E-408C-B814-CD2590F5B2B1Q33918138-60611FFC-2397-4D62-ADBB-D8984A1ED280Q34089190-2F867411-66F6-4448-B1FA-DB03642C013DQ34124018-3513DB46-37C0-449F-9FEA-4926790A4F24Q34268661-DB2B6D98-EA3C-43BE-B822-93A58F279941Q34629808-2781B362-26A1-484D-9FE2-97DB2D7F16F2Q34965829-D22DEAE7-9B05-480A-879E-5CC7C0F7D288Q35236946-05C14983-E02A-491C-ABC1-BDEBE76CF5BBQ36238152-63C6225F-7A2F-42EE-B3FC-69709FAEE246Q36648834-69B036F9-23F4-4CFC-B161-CC447B85DE03Q37086154-3454CD4C-7C8D-4442-B86D-4CB4F8B05081Q37197647-BED20653-47AB-49BB-92CE-E39B2A632051Q37230022-E8FD0FDC-157F-437B-AFE8-270DB0ACCCFCQ37252037-75877E48-5982-42D6-B359-D29AD7198216Q37660272-5C5FC9BD-45F2-446B-A9ED-23936C437A12Q37739960-A15227A8-5F4C-4FBA-8AF6-F18A6CEEDAF4Q37815815-A903D622-83C9-4903-A797-9FD9CD3B949DQ37833957-B0EEB528-4309-4BED-BDA7-8A858C0F0F85Q37835057-7951100D-FA31-4A62-8E38-0A0C3AB38F7EQ37847640-D1DB8C4B-86E7-4484-8471-04BD051B5DB6Q37887651-35BFD3F4-92CD-4A7D-8F18-003C373CF98FQ37887668-D5D94E22-4511-4561-8499-30E6FA5DB97DQ37929668-CD0D22AA-CA37-4C45-AA0C-ABCEA5F9E788Q37993491-E6EE53CB-F8A7-4963-9FBA-95808832922AQ37993495-515CCA58-87C9-47D5-8A0E-3B7444BE4F34Q37993502-B7D0AE6F-878B-498C-8A7A-C52E2CC2B6BBQ38065550-61E9CA54-081F-4EDF-98F0-581971C2FE17Q38109747-7930133B-B242-48E3-B5AA-DDDDCA9CC7DBQ38159138-38CFBF15-FDE1-4E1C-AE94-909B756E6C52Q38200682-5722E224-F615-4447-9224-39A4344DEB58Q38212576-8CF36243-F248-48D7-91DE-BBE77A6A3F66Q38227117-1BF3D6C0-D5DA-4D8A-8D4D-FC17B469C964Q38242981-AC67309C-8D0F-427E-997C-D78826DF1A01Q38329020-2C1F457F-438B-4E3D-887D-F8CDA45C117A
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marcus J Drake
@nl
Marcus J Drake
@sl
Marcus J. Drake
@en
Marcus J. Drake
@es
type
label
Marcus J Drake
@nl
Marcus J Drake
@sl
Marcus J. Drake
@en
Marcus J. Drake
@es
prefLabel
Marcus J Drake
@nl
Marcus J Drake
@sl
Marcus J. Drake
@en
Marcus J. Drake
@es
P1053
C-4542-2014
P106
P1153
7202439488
P21
P2798
P31
P3835
marcus-drake2
P496
0000-0002-6230-2552